Biomarin Pharmaceutical Inc. has a market cap of $4.03 billion; its shares were traded at around $35.31 with and P/S ratio of 10.7.
This is the annual revenues and earnings per share of BMRN over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of BMRN.
CEO Recent Trades:
- CEO Jean Jacques Bienaime sold 1,000 shares of BMRN stock on 09/28/2011 at the average price of 32. Jean Jacques Bienaime owns at least 126,093 shares after this. The price of the stock has increased by 10.34% since.
- CEO Jean Jacques Bienaime sold 2,000 shares of BMRN stock on 08/30/2011 at the average price of 29.01. Jean Jacques Bienaime owns at least 127,093 shares after this. The price of the stock has increased by 21.72% since.
- CEO Jean Jacques Bienaime sold 2,000 shares of BMRN stock on 08/19/2011 at the average price of 26.75. Jean Jacques Bienaime owns at least 127,093 shares after this. The price of the stock has increased by 32% since.
- CEO Jean Jacques Bienaime sold 3,000 shares of BMRN stock on 08/12/2011 at the average price of 27.1. Jean Jacques Bienaime owns at least 127,093 shares after this. The price of the stock has increased by 30.3% since.
- CEO Jean Jacques Bienaime sold 8,000 shares of BMRN stock on 08/02/2011 at the average price of 30.27. Jean Jacques Bienaime owns at least 127,093 shares after this. The price of the stock has increased by 16.65% since.
CFO Recent Trades:
- SVP, CFO Jeffrey H Cooper sold 2,500 shares of BMRN stock on 11/01/2011 at the average price of 33.26. Jeffrey H Cooper owns at least 40,104 shares after this. The price of the stock has increased by 6.16% since.
- SVP, CFO Jeffrey H Cooper sold 18,379 shares of BMRN stock on 10/10/2011 at the average price of 34. Jeffrey H Cooper owns at least 39,876 shares after this. The price of the stock has increased by 3.85% since.
- SVP, CFO Jeffrey H Cooper sold 18,379 shares of BMRN stock on 09/28/2011 at the average price of 32. Jeffrey H Cooper owns at least 39,876 shares after this. The price of the stock has increased by 10.34% since.
- SVP, CFO Jeffrey H Cooper sold 2,500 shares of BMRN stock on 09/01/2011 at the average price of 29.41. Jeffrey H Cooper owns at least 39,876 shares after this. The price of the stock has increased by 20.06% since.
- SVP, CFO Jeffrey H Cooper sold 18,036 shares of BMRN stock on 08/02/2011 at the average price of 30.47. Jeffrey H Cooper owns at least 39,876 shares after this. The price of the stock has increased by 15.88% since.
This is the insider trade history vs. stock price of BMRN. For the complete insider trading history of BMRN, click here.
Directors and Officers Recent Trades:
- VP, Human Resources Mark Wood sold 1,854 shares of BMRN stock on 12/22/2011 at the average price of 33.79. Mark Wood owns at least 20,634 shares after this. The price of the stock has increased by 4.5% since.
- VP, Human Resources Mark Wood sold 1,855 shares of BMRN stock on 11/22/2011 at the average price of 32.18. Mark Wood owns at least 20,634 shares after this. The price of the stock has increased by 9.73% since.
- SVP, General Counsel George Eric Davis sold 260 shares of BMRN stock on 11/01/2011 at the average price of 33.23. George Eric Davis owns at least 39,651 shares after this. The price of the stock has increased by 6.26% since.
- EVP, Chief Business Officer Steve Aselage sold 16,875 shares of BMRN stock on 10/28/2011 at the average price of 35. Steve Aselage owns at least 46,478 shares after this. The price of the stock has increased by 0.89% since.
- VP, Human Resources Mark Wood sold 1,853 shares of BMRN stock on 10/24/2011 at the average price of 33.32. Mark Wood owns at least 20,634 shares after this. The price of the stock has increased by 5.97% since.
For the complete insider trading history of BMRN, click here.







